Dossier - Page 1 - FirstWord Reports

Learn More Trends in Digital Patient Engagement

Embedding digital patient engagement throughout the patient journey Pharma companies have made good progress with digital delivery within innovative patient support programs—but there is still significant scope to...

Compare
Learn More Injectables and Implantables

Injectables and implantables are key to advancing patient centricity and adherence The development of controlled and prolonged release injectable and implantable drugs has seen huge leaps forward in recent years...

Compare
Learn More The Digitisation of Diabetes: Opportunities and Challenges for Industry

Assessing the revolutionary impact of digital technologies on the management of diabetes Advanced digital technologies and devices are driving fundamental change in the management of both Type 1 and 2...

Compare
Learn More Biosimilars: Go-to-Market Case Studies

As the biosimilar sector matures, what are the key issues that are shaping commercial strategies? As physician and payer confidence in the use of biosimilars grows, US and European companies are having to rethink their...

Compare
Learn More Digital Technologies: New Strategies for Customer Engagement

Digital technology is transforming customer engagement Pharma has embraced the digital revolution with open arms—clearly it offers exciting new opportunities for customer engagement. But initial enthusiasm...

Compare
Learn More Market Access for Cell and Gene Therapies

Pharma challenged to rethink its market access strategies While the promise of cell and gene therapy (C&GT) to deliver enduring or even curative treatments is welcomed there is no long-term market experience and...

Compare
Learn More Partnering in Digital Health: Pharma and Tech Companies

The secret of successful digital health partnerships Digital health is guaranteed to play a huge part in the future of pharma. Innovative technology that can improve patient access, increase quality of care, boost...

Compare
Learn More Paying for Digital Health: Payer Insights (2019)

Which digital health technologies are exciting payers? How and where can digital health technology improve patient outcomes and save payers money? Across the digital health field there are hundreds of applications...

Compare
Learn More Pricing and Reimbursement in Oncology

Payers want pharma to address the challenges they face Specialised cancer therapies such as checkpoint inhibitors have significantly improved outcomes for patients—but for payers they represent a growing pricing...

Compare
Learn More Real World Evidence: The Role of Medical Affairs

How well has RWE integrated into Medical Affairs—and should more be done? Payers and other stakeholders increasingly expect to see real world evidence (RWE) to support their decision making. Since being added to...

Compare
Learn More The Role of Patient Journey Mapping in Patient Engagement

Are you employing the latest technology and techniques to power your patient journey mapping? "Pharma companies first need to understand that their task is not to produce new product; their task is to provide a really...

Compare
Learn More Biomarkers and Companion diagnostics: Payer Insights

What do you need to do to get payer support for companion diagnostics and biomarkers? The investment decisions made by the biggest players in core disease areas drive market trends—so it's crucial to understand...

Compare
Learn More AI in Medical Diagnostics

Evaluating the potential of artificial intelligence to revolutionise and expand medical diagnostics Artificial intelligence (AI) driven technologies have already radically changed practice and outcomes in medical...

Compare
Learn More Health Insurance Disruptors: Going Digital

Health insurance: how to thrive in an increasingly digital health world Health insurers are being challenged to develop a portfolio of digital services with limited knowledge of their effectiveness and at a considerable...

Compare
Learn More Innovative drugs: Mapping the Pricing and Reimbursement Landscape (2020)

Drug innovation is delivering highly-effective medicines that significantly improve patient outcomes and, in some cases, are curative of disease. Yet of the 55 medicines that were approved in the US between January 2018...

Compare
Learn More Interoperability in Health

Experts agree interoperability will unlock considerable value across healthcare Interoperability—enabling information systems to share data—offers a wealth of opportunities for multiple health stakeholders,...

Compare
Learn More Pricing Transparency in Pharma

Pharma challenged to engage and shape the drug pricing transparency debate Anxieties about rising drug prices is fuelling an ever louder global demand for price transparency—and reformers are getting their message...

Compare
Learn More Regulating Digital Health

As digital health progressively enters mainstream therapy, how should it be regulated and to what outcome? Digital health is booming and as investment in digital health technology grows more products and services will...

Compare
Learn More The Future of Disease Interception

What does pharma need to do to develop this radical health model of the future? Disease interception is a novel healthcare model that identifies, treats and sometimes cures disease before it is fully manifested. There...

Compare
Learn More The Future of Personalised Medicine: The Role of Simulation and Digital Twins

Beyond the hype, where might simulation and digital twin technology deliver value for pharma? There is considerable excitement about the potential for simulation and digital twin technology to drive the personalised...

Compare

Browse by